$4.85
+0.00 (+0.00%)
Open$4.80
Previous Close$4.85
Day High$5.05
Day Low$4.75
52W High$12.70
52W Low$5.30
Volume—
Avg Volume8.6K
Market Cap1.92M
P/E Ratio—
EPS$-4.96
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+100.4% upside
Current
$4.85
$4.85
Target
$9.72
$9.72
$6.32
$9.72 avg
$10.76
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 493.3K | 481.3K | 473.6K |
| Net Income | 115.4K | 80.6K | 101.2K |
| Profit Margin | 23.4% | 16.8% | 21.4% |
| EBITDA | 189.6K | 155.0K | 161.9K |
| Free Cash Flow | 102.8K | 100.3K | 125.4K |
| Rev Growth | +17.7% | -1.9% | +10.9% |
| Debt/Equity | 0.11 | 0.15 | 0.11 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |